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Abstract
Purpose The present study investigated different doses of ultraviolet-A (UV-A) light on plasma nitric oxide metabolites and 
cardiorespiratory variables.
Methods Ten healthy male participants completed three experimental conditions, 7 days apart. Participants were exposed to 
no light (CON); 10 J cm2 (15 min) of UV-A light (UVA10) and 20 J cm2 (30 min) of UV-A light (UVA20) in a randomized 
order. Plasma nitrite  [NO2−] and nitrate  [NO3−] concentrations, blood pressure (BP), and heart rate (HR) were recorded 
before, immediately after exposure and 30 min post-exposure. Whole body oxygen utilization ( V̇O
2
 ), resting metabolic rate 
(RMR) and skin temperature were recorded continuously.
Results None of the measured parameters changed significantly during CON (all P > 0.05). V̇O
2
 and RMR were significantly 
reduced immediately after UVA10 (P < 0.05) despite no change in plasma  [NO2−] (P > 0.05). Immediately after exposure 
to UVA20, plasma  [NO2−] was higher (P = 0.014) and V̇O2 and RMR tended to be lower compared to baseline (P = 0.06). 
There were no differences in  [NO2−] or V̇O2 at the 30 min time point in any condition. UV-A exposure did not alter systolic 
BP, diastolic BP or MAP (all P > 0.05). UV-A light did not alter plasma  [NO3−] at any time point (all P > 0.05).
Conclusions This study demonstrates that a UV-A dose of 20 J  cm2 is necessary to increase plasma  [NO2−] although a smaller 
dose is capable of reducing V̇O
2
 and RMR at rest. Exposure to UV-A did not significantly reduce BP in this cohort of healthy 
adults. These data suggest that exposure to sunlight has a meaningful acute impact on metabolic function.
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ANOVA  Analysis of variance
BP  Blood pressure
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J cm2  Joules per centimeter squared
Kg  Kilograms
L  Liter
MAP  Mean arterial BP
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µM  Micromolar
mM  Millimolar
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nm  Nanometers
nM  Nanomolar
NO3−  Nitrate
NO  Nitric oxide
NOS  Nitric oxide synthases
NO2−  Nitrite
n  Number
V̇O
2
  Oxygen utilization
RMR  Resting metabolic rate
NaOH  Sodium hydroxide
SEM  Standard error of the mean
SBP  Systolic BP
RXNO  Total nitrosated products
UV  Ultraviolet
UV-A  Ultraviolet-A
UVR  Ultraviolet radiation
w/v  Weighted volume
XOR  Xanthinine oxioreductases
ZnSO4  Zinc sulfate
UVA10  10 J cm2
UVA20  20 J cm2
Introduction
Nitric oxide (NO) is produced by NO synthases (NOS) 
from the oxidation of l-arginine and acts as a multifunc-
tional signaling molecule that regulates a number of key 
biological processes including neuronal signaling, immune 
function, mitochondrial respiration, and vascular tone (Carr 
and Ferguson 1990; Moncada and Higgs 1991; Stamler et al. 
1994). NO is rapidly oxidized within the human body to 
nitrite  (NO2−) and nitrate  (NO3−), with the latter account-
ing for the majority of NO-derived compounds within the 
body. Recent evidence suggests that  NO3− and  NO2− are 
important reservoirs of NO that act independently of NOS 
activity (Lundberg et al. 2009, 2015). Although  NO3− is 
considered to be physiologically inert, it can be reduced 
to biologically active  NO2− by bacteria in the oral cavity 
(Duncan et al. 1995) and gut (Tiso and Schechter 2015) or 
reduced by xanthine oxidoreductases (XOR) (Lundberg et al. 
2009).  NO2− can initiate physiological effects or be reduced 
further to NO under hypoxic (Castello et al. 2006) and acidic 
(Modin et al. 2001) conditions.
Several studies have demonstrated that increasing plasma 
levels of  NO3− and  NO2− through dietary  NO3− ingestion 
and via sunlight exposure can reduce blood pressure (BP) 
(Larsen et al. 2006; Webb et al. 2008; Opländer et al. 2009; 
Kapil et al. 2010; Vanhatalo et al. 2010; Siervo et al. 2013; 
Wylie et al. 2013; Muggeridge et al. 2015; McIlvenna et al. 
2017). Increasing the circulating concentration of NO 
metabolites has also been shown to elicit other cardiovascu-
lar and metabolic effects, including the reduction of resting 
oxygen utilization ( V̇O
2
 ) (Larsen et al. 2014; Whitfield et al. 
2016). Intriguingly, both dermis and epidermis contain 
 NO2− at concentrations substantially greater than those in 
blood (Paunel et al. 2005). Exposing the skin to light in the 
UV-A wavelength range (315–400 nm) leads to photodecom-
position of these NO derivatives and release of NO into the 
circulation with consequent biological effects (Paunel et al. 
2005; Mowbray et al. 2009; Suschek et al. 2010). UV-A 
induced NO production has been shown to be independ-
ent of NOS, temperature, and vitamin D status (Liu et al. 
2014). Given that basal plasma  [NO2−] is suggested to be a 
marker of endothelial function (Kleinbongard et al. 2006), 
whereby low levels correlate with increased cardiovascular 
risk (Allen et al. 2009), UV-A induced NO production could 
conceivably modulate cardiovascular homeostasis.
Despite the potential health significance of these obser-
vations, little is known about the minimal dose of UV-A 
exposure required to alter circulating NO levels. Whole 
body UV-A exposure of 20 J cm2 (equivalent to ~ 30 min 
of Mediterranean summer sunlight) has been consistently 
shown to mobilize  NO2− from the skin into the plasma (Liu 
et al. 2014) and reduce systemic BP (Opländer et al. 2009; 
Liu et al. 2014; Muggeridge et al. 2015). To the best of our 
knowledge, this has been the only dose of UV-A used in 
human volunteer studies related to the mobilization of NO 
from skin. However, it has been shown in vitro that UV-A 
light of 9 J cm2 causes a dose-dependent increase in NO 
production in isolated keratinocytes without causing DNA 
damage (Holliman et al. 2017). This may be important as 
current public health messages favor sun avoidance due to 
the established carcinogenic effects of habitual UV exposure 
(Kennedy et al. 2003; Rigel 2008). Given that exposure to 
sunlight may impact positively on markers of cardiovascular 
health, further research is warranted to determine the mini-
mum dose of UV-A exposure to elicit these effects.
Therefore, the primary aim of the present study was to 
compare the effects of two different doses of UV-A light on 
plasma  [NO2−]. Additional aims were to examine the effects 
of the same doses of UV-A light on  [NO3−], BP, resting V̇O2 
and RMR. We hypothesized that UV-A light would increase 
plasma NO derivatives and reduce BP and resting V̇O
2
 in a 
dose-dependent manner.
Methods
Participants
Ten healthy males (age 28 ± 5 years, stature 180 ± 9 cm, 
body mass 80.8 ± 11.0 kg) volunteered to participate in the 
study following ethical approval by the School of Science 
and Sport Ethics Committee at the University of the West 
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of Scotland. Participants self-determined their skin types 
via the Fitzpatrick Skin Questionnaire (Fitzpatrick 1988) as 
skin type 2 (n = 1) and skin type 3 (n = 9). Written informed 
consent was obtained from all participants prior to the com-
mencement of the study. All participants were non-smokers, 
apparently healthy, were not regular users of anti-bacterial 
mouthwash, and reported no use of medication. Prior to each 
trial, participants were instructed to avoid prolonged sunlight 
exposure and caffeine on the morning of each visit and to 
avoid  NO3− rich foods (such as beetroot and lettuce), high 
intensity exercise, and alcohol consumption within 48 h of 
each trial.
Experimental design
Each participant attended the laboratory on three separate 
occasions and was exposed to either no light (control, CON), 
10 J cm2 of UV-A light (UVA10), or 20 J cm2 of UV-A 
light (UVA20), in a randomized counter-balanced order. 
Each condition was separated by 7 days and performed at 
the same time of day for each participant. Trials were per-
formed in Scotland at 55.78°N latitude between July and 
December. Each trial was conducted in the morning (before 
11 a.m.) after an overnight fast and following the consump-
tion of ~ 500 mL of bottled water upon awakening. Dietary 
and exercise habits were self-recorded via a 48 h recall at the 
beginning of visit one and repeated on each visit thereafter. 
Compliance to these factors was determined at the beginning 
of each visit.
UV‑A exposure
Whole body UV-A exposure was delivered using a com-
mercially available UV-A light therapy system (Waldmann, 
UV302 L, Germany). UV-A light occurs naturally in the 
315–400 nm wavelength band, and the present system emit-
ted light at wavelengths between 315 and 351 nm. In all 
conditions, participants lay supine on a medical plinth for 
the duration of the experiment and wore shorts and protec-
tive glasses. Participants were instructed to close their eyes 
for the duration of the light exposures. During CON, the 
UV-A system remained off. The trials were conducted in a 
temperature-controlled laboratory (22 ± 1.3 °C). The dose of 
UV-A was automatically calculated based on exposure time 
and calibrated irradiance at a distance of 21 cm from the 
abdominal skin. Exposure time was 15 min in UVA10 and 
30 min in UVA20. Calibration of the UV-A light source was 
conducted as per the manufacturer’s instructions.
Experimental procedures
On arrival, stature and body mass were recorded following 
the bladder void. Upon lying supine for a period of 30 min 
prior to baseline measurements, an intravenous catheter 
was inserted into the antecubital vein of each participant for 
collection of venous blood samples. In the UVA10 condi-
tion, participants lay supine for an additional 15 min prior 
to baseline measurements to time-match the duration of the 
experiment across all three conditions. Skin temperature 
was continuously monitored (Squirrel SQ2022, Cambridge, 
England) via thermistors placed at four anatomical sites (tri-
ceps, chest, quadriceps, and calf). Participants were fitted 
with a heart rate (HR) monitor (Polar Electro, Oy, Finland), 
which was continuously monitored by telemetry. Resting 
V̇O
2
 was measured via indirect calorimetry using breath-
by-breath analysis (Medgraphics, Milan, Italy). The volume 
measurement of the system was calibrated prior to each trial 
using a 3-L syringe as per the manufacturers’ instructions. 
Gas analyser calibration was performed with two gases of 
known concentrations (calibration gas: 5% carbon dioxide, 
12% oxygen and nitrogen balance and reference gas: 21% 
oxygen and nitrogen balance) (Air Liquide Healthcare, Bel-
gium). Resting V̇O
2
 data were taken as an average for 20 min 
at baseline, during treatment, and for 30 min post-exposure. 
Upper and lower limits of agreement were calculated for 
resting V̇O
2
 , and data points exceeding two standard devia-
tions from the mean were excluded from analysis. Resting 
metabolic rate (RMR) was estimated using the following 
equation: RMR = V̇O
2
 (L/min−1) × calorific value. The calo-
rific values were calculated from the respiratory exchange 
ratio using data from Lusk (1923). Brachial BP was meas-
ured in triplicate with 1 min between measures at baseline, 
immediately after light exposure (0 min), and 30 min after 
exposure using a manual stethoscope and sphygmomanom-
eter (Accoson, London, UK), with the pressure cuff placed 
at the upper part of the non-dominant arm positioned at the 
level of the right atrium. Mean values were used for analysis. 
Mean arterial BP (MAP) was calculated using the following 
equation: MAP = [(2 × diastolic pressure + systolic pres-
sure)/3]. Following each BP measure, 8 mL of venous blood 
was collected from the opposite arm at baseline, 0 min, and 
30 min post-exposure. Blood was collected in vacutainers 
containing EDTA and immediately centrifuged at 4000 rpm 
at 4 °C for 10 min (Harrier 18/80, MSE, UK). Plasma was 
extracted and immediately stored at − 80 °C for later analysis 
of  [NO3−] and  [NO2−]. Intravenous lines were flushed with 
2 mL of 0.9% saline solution immediately following each 
blood draw.
Analysis of plasma NO metabolites
Gas-phase chemiluminescence was used to determine 
plasma  [NO3−] and  [NO2−], as previously described (Pinder 
et al. 2008; Muggeridge et al. 2014; McIlvenna et al. 2017). 
Briefly, following the creation of a standard curve at sev-
eral concentrations (0–1000 nM for  NO2−) and (0–100 µM 
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for  NO3−), samples were thawed in a water bath at 37 °C 
for 3 min. Plasma samples were injected in duplicate into a 
customized enclosed purge vessel containing the respective 
reagent mixture. For the determination of  NO2−, a reagent 
containing 1% sodium iodide in 4 mL of glacial acetic acid 
kept at 50 °C was used to reduce  NO2− to NO.
Before the determination of  NO3−, plasma samples 
were deproteinized using zinc sulfate  (ZnSO4) and sodium 
hydroxide (NaOH). Samples were made up in 1 mL aliquots 
(200 µL plasma: 400 µL  ZnSO4 (10% w/v) and 400 µL 
NaOH solution (200 µL de-ionized water: 200 µL 1 M 
NaOH) and vortexed for 30 s. Samples were then centri-
fuged at 4000 rpm for 5 min and supernatants were used for 
 NO3− analysis. For the determination of  NO3−, a reagent 
containing 32 mg of vanadium trichloride  (VCl3), 4 mL of 
1M hydrochloric acid, and 500 µL of de-ionized water was 
used in a sealed purge vessel maintained at 95 °C. NO was 
quantified using an NO analyzer (Sievers NOA 280; Ana-
lytix, UK). The area under the curve (AUC) was then used 
to determine concentrations by plotting the standard curve 
and dividing the AUC of each sample by the gradient of the 
slope. The co-efficient of variance (COV) for both plasma 
 [NO2−] and  [NO3−] was better than 5%.
Data analysis
The distribution of the data was tested using the Shap-
iro–Wilk test. A two-way repeated-measures ANOVA was 
used to examine the differences between ‘condition’, ‘time’ 
and the ‘condition × time’ interaction for all variables. Post 
hoc analysis of the significant main effects was conducted 
using paired t tests and adjusted for multiple comparisons 
using the Bonferroni correction. Statistical significance was 
accepted at P < 0.05. The inclusion of 95% CI for mean dif-
ferences is presented with P values and effect sizes (Cohen’s 
D), when appropriate. Effect sizes were interpreted as: 
small effect > 0.2; medium effect > 0.5; large effect > 0.8. 
Data were analyzed using SPSS (version 22.0) and Graph 
Pad Prism (version 7.02). Data in the text are presented as 
mean ± standard deviation. Data in figures are presented as 
group delta (Δ) ± standard error of the mean (SEM) relative 
to pre-treatment baselines.
Results
NO metabolites
Plasma  [NO2−] changes are shown in Fig.  1a. Plasma 
 [NO2−] was not different between the three conditions at 
baseline (CON 109 ± 54 nM, UVA10 108 ± 55 nM, UVA20 
162 ± 75 nM, P = 0.18). There was a significant main effect 
of ‘condition’ (P = 0.004), ‘time’ (P = 0.001) and ‘con-
dition × time’ interaction (P < 0.001) on plasma  [NO2−]. 
Following UVA20, plasma  [NO2−] was increased from base-
line at the 0 min time point (95% CI 25.7–216.9; P = 0.014; 
d = 1) but was not different at 30 min (P = 1.0; d = 0.2). 
Plasma  [NO2−] did not differ from baseline at the 0 min or 
the 30 min time points in both the CON and UVA10 trials 
(all P > 0.4, d < 0.3).
Changes in plasma  [NO3−] are shown in Fig. 1b. Plasma 
 [NO3−] was different between the three conditions at base-
line (CON 45.6 ± 16.2 µM, UVA10 55.1 ± 21.9 µM, UVA20 
39.5 ± 16.8 µM, P = 0.04). Post hoc comparisons revealed 
baseline plasma  [NO3−] was higher in UVA10 compared to 
UVA20 (95% CI 0.4–31; P = 0.05; d = 1), but there was no 
difference between CON and UVA10 (P = 0.4) or CON and 
UVA20 (P = 0.9). There was a significant main effect for 
‘condition’ (P = 0.013) on plasma  [NO3−]. Overall, plasma 
 [NO3−] was significantly higher in UVA10 when compared 
to UVA20 (95% CI 2.5–25.6; P = 0.02; d = 1), but was not 
different to CON (P = 0.7). There was no significant main 
effect for ‘time’ (P = 0.7) or ‘condition × time’ interaction 
(P = 0.109) for plasma  [NO3−].
Blood pressure, heart rate and skin temperature
There was no significant ‘condition x time’ interaction for 
systolic BP (SBP) (P = 0.91; Table 1), diastolic BP (DBP) 
(P = 0.19; Table 1) or MAP (P = 0.27; Fig. 1c; Table 1). 
There was no difference in BP variables at baseline (P > 0.5; 
Table 1). Although no significant difference was observed 
in BP, effect sizes indicate that following UVA20, DBP 
reduced to a small extent immediately following (P = 0.3; 
d = 0.3) and 30 min (P = 0.15; d = 0.3) post-exposure. After 
UVA20, there was a small reduction in MAP immedi-
ately following exposure (P = 0.3; d = 0.3) and a moderate 
decrease 30 min after exposure (P = 0.1; d = 0.5) when com-
pared to baseline (Table 1). Skin temperature and HR data 
are shown in Table 1. There was no significant main effect 
of ‘condition x time’ for HR (P = 0.5). There was a trend 
towards a ‘condition × time’ interaction for skin tempera-
ture (P = 0.06). Effect sizes show a small increase in skin 
temperature immediately following UVA20 (d = 0.4), but no 
difference between any other time points (d < 0.2).
Resting V̇O
2
 and metabolic rate
There was a significant ‘condition × time’ effect on rest-
ing V̇O
2
 (P = 0.047; Fig. 1d). Resting V̇O
2
 was not different 
between the three conditions at baseline (CON 273 ± 37 mL/
min−1, UVA10 267 ± 32 mL/min−1, UVA20 269 ± 37 mL/
min−1; P = 0.8). Following UVA20, there was a trend for a 
reduction in resting V̇O
2
 at 0 min compared to the baseline 
(95% CI − 0.759 to 36.1, P = 0.061; d = 0.4), but values were 
not different at 30 min (P = 1; d < 0.2). Following UVA10, 
resting V̇O
2
 was significantly reduced at 0 min (95% CI 
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0.837–16.3; P = 0.03; d = 0.3) but did not differ from base-
line 30 min after exposure (P = 1; d < 0.2). In CON, resting 
V̇O
2
 did not change at 0 or 30 min (both P = 1; d < 0.2).
There was a significant ‘condition x time’ effect on rest-
ing RMR (P = 0.041). RMR was not different between the 
three conditions at baseline (CON 1917 ± 260 kcal/day−1, 
UVA10 1860 ± 223 kcal/day−1, UVA20 1883 ± 259 kcal/
day−1; P = 0.5). Following UVA20, there was a trend for 
a reduction in RMR at 0 min compared to the baseline 
(Δ129 ± 42  kcal/day−1, 95% CI − 5 to 453, P = 0.056; 
d = 0.4), but values were not different at 30 min (P = 0.91; 
d < 0.2). Following UVA10, RMR was significantly reduced 
at 0 min (Δ57 ± 14 kcal/day−1, 95% CI 6–114; P = 0.04; 
d = 0.3) but did not differ from baseline 30 min after expo-
sure (P = 1; d < 0.2). In CON, resting V̇O
2
 did not change at 
0 or 30 min (both P = 1; d < 0.2).
Discussion
Exposure to 20 J cm2 of UV-A light, a dose equivalent 
to approximately 30 min of Mediterranean summer sun-
light (Diffey 2002), has previously been shown to increase 
plasma  [NO2−] and lead to a sustained reduction in BP 
(Opländer et al. 2009; Liu et al. 2014). The present study 
explored the effects of different doses of UV-A exposure 
and the effects on circulating NO metabolites, BP, and 
resting V̇O
2
 . The principal findings were that 20 J cm2 of 
UV-A exposure resulted in a brief, but significant increase 
in plasma  [NO2−] whereas 10 J cm2 was insufficient to 
alter the concentration of this NO metabolite. In contrast 
to previous findings, exposure to UV-A light in either dose 
did not alter BP. However, we here demonstrate for the 
first time that exposure to UV-A light reduces resting V̇O
2
 
and RMR. While these data suggest that a minimum dose 
of 20 J cm2 is necessary to augment plasma NO avail-
ability, further work is required to better understand the 
Fig. 1  a Plasma  [NO2−]; b plasma  [NO3−]; c mean arterial pres-
sure; and d resting oxygen utilization ( V̇O
2
 ), d following no exposure 
[CON (circles)], 10 J cm2 [UVA10 (squares)], and 20 J cm2 [UVA20 
(triangles)] of UV-A light.  Data are presented as the  group delta 
mean ± SEM. Shaded area signifies the period of UV-A light expo-
sure in UVA10 and UVA20. *Denotes significant increase in plasma 
 NO2− compared to baseline
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therapeutic effects of UV-A light on cardiovascular and 
metabolic health.
Dose-dependent effects of UV-A light on NO metabolites
The observed increase in plasma  [NO2−] following 20 J cm2 
but not 10 J cm2 of UV-A light supports our original hypoth-
esis that the UV-induced release of NO metabolites from 
the skin is dose dependent. The higher dose of UV-A light 
is proportional to approximately 30  min of Mediterra-
nean summer sunlight (Liu et al. 2014). We demonstrate 
that 20 J cm2 of UV-A light increased plasma  [NO2−] by 
75% immediately following cessation of exposure, which 
is higher than the proportional increases of 45% (Opländer 
et al. 2009) and 40% (Liu et al. 2014) that have been previ-
ously reported. On the other hand, the absolute increase in 
plasma  [NO2−] was higher (~ 200 nM) in the study by Liu 
and colleagues (2014) than in the present study (123 nM). 
Collectively, the present study and other studies in the area 
(Opländer et al. 2009; Liu et al. 2014; Muggeridge et al. 
2015) suggest that UV-A induced NO production may alter 
the overall circulating pool of NO. However, it is clear that 
there is profound inter-individual variability of  NO2− fol-
lowing UV-A challenge (Opländer et al. 2009). This may 
be explained by recent data from Holliman and colleagues 
(2017) who demonstrated diverging baseline levels of skin 
NO content in their skin donors and a variable magnitude 
of NO release from isolated keratinocytes in response to 
UV-A exposure. Both age and body composition are known 
to influence the storage and release of NO metabolites from 
the skin (Ma et al. 2015). These variables, along with skin 
type and habitual sunlight exposure may help explain the 
divergent response to UV-A between individuals and study 
cohorts. The total storage of NO metabolites in the skin is 
likely to be important as it has recently been demonstrated 
in vitro that  NO2− is converted to NO upon UV-A exposure 
(Holliman et al. 2017).
In contrast to previous findings (Opländer et al. 2009; Liu 
et al. 2014), the observed increase in plasma  [NO2−] imme-
diately following exposure with 20 J cm2, was not sustained 
30 min post-exposure. One possible explanation is that the 
source and delivery method for the UV-A light differed 
between all of these studies involving human volunteers. 
We speculate that the overall ‘dose’ or intensity of light may 
contribute to diverging  NO2− release and overall NO kinet-
ics. Previous studies have utilized the same dose of 20 J cm2 
of UV-A light (Opländer et al. 2009; Liu et al. 2014; Mug-
geridge et al. 2015), however, over different time periods and 
intensities. In the present study, the intensity of light was 
the same in UVA10 and UVA20, where exposure time was 
manipulated to alter the overall dose. In vitro experiments 
highlight the relevance of the UV-A source showing that 
overall NO kinetics are altered depending on the distance 
from the UV-A light source (Dejam et al. 2003) and poten-
tially the specific wavelength of the light. The middle to long 
UV-A wavelength range of 340–400 nm has been shown to 
be the major contributor to overall NO production in isolated 
keratinocytes in response to UV-A challenge (Holliman et al. 
2017). In the present study, our UV-A light source emitted 
its maximum intensity at 351 nm. It should be highlighted, 
however, that natural sunlight contains light in the UV-B 
wavelength which will increase production of vitamin  D3, 
and potentially cause erythema and DNA damage (Marion-
net et al. 2015). A key question remains, therefore, as to 
whether the release of NO metabolites differs in response to 
natural or artificial sources of light.
In contrast with previous research, plasma  [NO3−] was 
not altered by UV-A exposure. Liu and colleagues (2014) 
have previously demonstrated that 20 J cm2 of UV-A light 
reduced  [NO3−] by ~ 3 µM. The authors speculated that 
UV-A exposure may result in direct photolysis of  NO3− to 
yield NO. Alternatively, it was suggested that UV-A expo-
sure may release  NO3− from skins stores which in turn 
would enhance the reduction of  NO3− to  NO2− via facul-
tative bacteria in the oral cavity (Duncan et al. 1995) and 
gut (Tiso and Schechter 2015) or by XOR (Lundberg et al. 
2009). However, the authors noted that the decline in plasma 
 [NO3−] was over ten times the increase in  [NO2−] which 
Table 1  Blood pressure, skin temperature and heart rate variables in 
each condition pre, immediately after cessation (0 min) and half an 
hour following UV-A light exposure
Data are presented as mean ± SEM
a Denotes a small effect size change compared to baseline
b Denotes a moderate effect size change compared to baseline 
(Cohen’s D)
Condition and variable Baseline 0 min 30 min
CON
 Systolic BP (mmHg) 116 ± 2 116 ± 3 115 ± 3
 Diastolic BP (mmHg) 70 ± 2 70 ± 3 71 ± 3
 MAP (mmHg) 85 ± 2 85 ± 3 85 ± 3
 Heart rate (beats  min−1) 60 ± 3 60 ± 3 58 ± 3
 Skin temperature (oC) 32 ± 0 32 ± 0 32 ± 0
UVA10
 Systolic BP (mmHg) 115 ± 1 115 ± 1 115 ± 1
 Diastolic BP (mmHg) 71 ± 2 70 ± 2 70 ± 2
 MAP (mmHg) 86 ± 1 85 ± 2 85 ± 2
 Heart rate (beats  min−1) 58 ± 2 59 ± 3 55 ± 2
 Skin temperature (oC) 32 ± 0 33 ± 0 32 ± 0
UVA20
 Systolic BP (mmHg) 115 ± 1 113 ± 2 113 ± 2
 Diastolic BP (mmHg) 69 ± 2 67 ± 3a 67 ± 2a
 MAP (mmHg) 85 ± 2 83 ± 2a 82 ± 2b
 Heart rate (beats  min−1) 58 ± 3 58 ± 2 55 ± 3b
 Skin temperature (oC) 33 ± 0 34 ± 0a 33 ± 0
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suggests the reduction in BP following UV-A exposure 
resulted from bioactivation of cutaneous rather than circulat-
ing NO stores. More recent data now suggest that photolysis 
of  NO3− to NO by UV-A light seems unlikely (Holliman 
et al. 2017). These authors demonstrated that irradiation of a 
solution of sodium  NO2− released NO in a dose-dependent 
manner. Conversely, irradiation of sodium  NO3− did not 
yield NO. While these contrasting data between the present 
research and that of Liu and colleagues (2014) are not read-
ily explainable, it is conceivable that the aforementioned 
differences in UV-A delivery methods may be important. 
Alternatively, inter-individual variability in the release of 
NO metabolites following UV-A exposure (Oplander et al. 
2009; Holliman et al. 2017) and the multiple biological fates 
of these molecules may help to explain these notable dif-
ferences. While future research is warranted to elucidate 
the role of skin and circulating stores of  NO3−, it seems 
likely that the consistently reported bioactivation of  NO2− is 
responsible for the myriad of physiological effects that occur 
in response to UV-A exposure.
Blood pressure is not altered by UV-A light
Our study demonstrated that UV-A light did not significantly 
alter BP. This finding contrasted our study hypothesis and 
previous research which has demonstrated that 20 J cm2 
effectively reduces BP in a healthy cohort (Opländer et al. 
2009; Liu et al. 2014). Nevertheless, there was a moder-
ate reduction in MAP (d = 0.5) 30 min after exposure in 
the UV20 condition with a concomitant moderate reduc-
tion in heart rate (d = 0.5). While the clinical and biological 
significances of the small reduction in MAP (3 mmHg) in 
this study are unclear, a reduction of DBP by only 5 mmHg 
decreases risk for stroke by 34% (MacMahon et al. 1990) 
and any amount of BP reduction is protective against car-
diovascular mortality (Lawes et al. 2004). It should be high-
lighted that the small sample of participants in this study 
were all young, healthy, and normotensive males. The most 
likely explanation for the absence of a significant reduction 
in BP was that the elevation in plasma  [NO2−] was not sus-
tained long enough to elicit a pronounced biological effect.
The experimental procedures may also have limited the 
extent to which UV-A light may have reduced BP. Specifi-
cally, the measurement of BP following the treatments in 
each condition was preceded by a 1-h period of lying supine. 
The consequence is that this sustained period of lying supine 
likely induced postural venodilation (Gemignani et al. 2008) 
and lowered BP prior to the experimental intervention. 
Indeed, DBP was 70 ± 7 mmHg and MAP was 85 ± 6 mmHg 
at baseline across all three conditions. This may have limited 
any further biologically significant reductions in BP follow-
ing UV-A exposure. Recently, we have shown that posture 
and the period of time of lying supine can alter both BP 
and plasma  [NO2−] (Liddle et al. 2018), which emphasizes 
that posture should be carefully considered when conducting 
future research in this area.
UV-A light reduces V̇O
2
 and RMR
A notable finding in this study is that V̇O
2
 and RMR fell 
during both light exposures. To our knowledge, this study 
is the first to explore the effects of UV-A light on resting 
metabolism in humans. A significant reduction in resting 
V̇O
2
 was observed despite no elevation in plasma  [NO2−] 
during UVA10, whereas a trend for a reduction was found 
in the presence of a significant elevation in plasma  [NO2−] 
in UVA20. The reduction in V̇O
2
 following UV-A exposure 
appears to be transient, however, as values returned to base-
line 30 min after exposure in both light exposure conditions. 
While the mechanisms accounting for the reduction in V̇O
2
 
could not be ascertained in the present study, we speculate 
that the complexity of NO conversion and appearance from 
 NO2− or other nitrogen oxides following UV-A challenge 
may have accounted for this finding. We hypothesized that 
resting V̇O
2
 would be reduced in the presence of elevated 
 NO2− as others have shown that  NO2− inhibited respira-
tion by ~ 60% when applied to primary skeletal myotubes, 
in vitro (Larsen et al. 2011). Others have demonstrated 
that increasing plasma  [NO2−] and NO bioavailability via 
dietary  NO3− supplementation reduces V̇O2 at rest (Larsen 
et al. 2014; Whitfield et al. 2016). Larsen and colleagues 
(2014) speculated that the reduction in RMR was most likely 
due to an NO-mediated inhibition of cytochrome c oxidase 
(Carr and Ferguson 1990) and found that changes in this 
parameter following dietary  NO3− were independent of 
insulin sensitivity and thyroid hormones. However, Whit-
field and Colleagues (2016) observed a similar reduction in 
whole body V̇O
2
 at rest, in the absence of change in skeletal 
muscle mitochondrial respiration. It is conceivable that the 
changes in resting V̇O
2
 observed in the present study follow-
ing UV-A may have occurred via other NO-related mecha-
nisms involving species distinct from those of the canoni-
cal  NO3−–NO2−—NO pathway. It must also be considered 
that the absence of an elevation in plasma  NO2− following 
UVA10 and the presence in UVA20 may be indicative of an 
NO-independent mechanism.
Functional relevance of the findings
Given that NO plays a pivotal role in the regulation of vascu-
lar tone (Stamler et al. 1994) and glucose uptake (Balon and 
Nadler 1997; Bergandi et al. 2003), augmentation of NO bio-
availability through environmental exposure to UV-A light 
has the potential to have a profound impact on human health. 
The present data suggests that a minimum dose of 20 J cm2 
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of UV-A light is required to elicit a significant increase 
in plasma  NO2−, a known marker of NO availability. The 
potential total daily exposure to UV-A light during daylight 
hours is likely to exceed 20 J cm2 in most countries during 
the spring and summer months (Marionnet et al. 2015). This 
suggests that habitual exposure to sunlight may complement 
endogenous NO production and exogenous NO generation 
from dietary pathways although the aforementioned differ-
ences between artificial and natural light should be reempha-
sized at this stage. Clothing, working patterns, and leisure 
behaviors are also likely to have a considerable impact on the 
exposure of skin to UV-A light. Furthermore, in the winter 
months, countries further from the equator are likely to see 
daily UV-A exposure fall well below the minimum threshold 
required to increase  NO2− (Liu et al. 2014). Indeed, inci-
dences of acute coronary syndrome and stroke are known 
to be higher in winter (Rosengren et al. 1999; Oberg et al. 
2000). Importantly, epidemiological data also suggests that 
sunlight exposure reduces all-cause and cardiovascular mor-
tality (Yang et al. 2011; Brondum-Jacobsen et al. 2013). 
There may be value, therefore, in a targeted approach to 
increase NO availability via the ingestion of  NO3−-rich food 
and beverages during these periods of reduced UV exposure.
The long term effects of the reduction in resting V̇O
2
 and 
RMR following UV-A exposure are unclear but there may be 
positive effects on cellular function and signaling given that 
an augmented plasma  NO2− can improve mitochondrial effi-
ciency (Larsen et al. 2011). This may be particularly relev-
ent where tissue oxygen supply is reduced through either 
clinical (Kenjale et al. 2011) or environmental conditions 
(Muggeridge et al. 2014). Conversely, a sustained reduction 
in RMR must be considered as contraindicative for energy 
balance. For example, Hill et al. (2003) estimated that, on 
average, the gain of body weight over time was due to a posi-
tive energy balance of 15 kcal/day−1. This is substantially 
lower than the reductions in RMR which were induced by 
exposure to UV-A light in the present study (57–129 kcal/
day−1). This is of relevance given the composition of UV-A 
in overall sunlight exposure is approximately 90% although 
the intensity depends on latitude and seasonal variations in 
the light/dark cycle (Diffey 2002). These current data would 
seem to conflict with the suggestion that UV exposure is 
as a potential intervention for obesity (Geldenhuys et al. 
2014; Fleury et al. 2016), potentially mediated via vitamin 
D or NO effects (Gorman et al. 2017). The present study 
highlights the extent to which sunlight exposure may have 
a potentially confounding impact on key markers of cardio-
metabolic health; data which should be carefully considered 
in epidemiological research.
Limitations
The present study is not without limitations. First, the study 
lacked ecological validity in the sense that acute exposure to 
artificial UV-A light in the laboratory tells us little about the 
relevance of environmental sunlight exposure for habitual 
vascular homeostasis. Second, while our data suggests there 
is a minimum dose of UV-A light exposure that is required 
to elicit meaningful increases in NO bioavailability, the 
existence of a dose–response relationship cannot be ascer-
tained without more extensive investigations. Although we 
observed an increase in plasma  [NO2−] following 30 min of 
simulated sunlight exposure, we did not assess its release 
from skin stores and are therefore unable to provide a com-
prehensive assessment of the kinetic changes in NO deriva-
tives and release from the skin. Such data are necessary to 
truly understand the role of the skin in the regulation of NO 
bioavailability and to establish whether UV-A exposure may 
be cardioprotective.
Conclusions
The present study is the first to determine that at least 
20 J cm2 of UV-A exposure (~ 30 min of Mediterranean 
summer sunshine) is required to significantly increase 
plasma  [NO2−] in healthy human participants. Surprisingly, 
elevations in plasma NO availability were not met with a 
significant reduction in BP, which has been consistently 
observed in previous studies. These contrasting data may 
relate to experimental differences in UV-A exposure pro-
tocols or inter-individual variability in responses between 
participants. Although BP was not reduced in this study, 
UV-A exposure in doses of either 10 or 20 J cm2 reduced 
resting V̇O
2
 and RMR. These data provide further evidence 
to suggest that environmental exposures of sunlight may 
have a meaningful impact on cardiovascular and metabolic 
functions.
Author contributions CM, LM, DM, RW, and CE conceived and 
designed research. CM, LM, MB, and CE conducted experiments. CM, 
LM, LL, MB, BF, MF analysed plasma samples. CM, LL, DM, and 
CE performed the statistical analysis of the data. CM wrote the first 
draft of the manuscript. All authors revised the manuscript and read 
and approved the final version.
Compliance with ethical standards 
Conflict of interest The authors declare they have no conflict of inter-
est.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution 4.0 International License (http://creat iveco 
mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribu-
tion, and reproduction in any medium, provided you give appropriate 
1051European Journal of Applied Physiology (2018) 118:1043–1052 
1 3
credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made.
References
Allen JD, Miller EM, Schwark E et al (2009) Plasma nitrite response 
and arterial reactivity differentiate vascular health and per-
formance. Nitric Oxide Biol Chem 20:231–237. https ://doi.
org/10.1016/j.niox.2009.01.002
Balon TW, Nadler JL (1997) Evidence that nitric oxide increases glu-
cose transport in skeletal muscle. J Appl Physiol 82:359–363
Bergandi L, Silvagno F, Russo I et al (2003) Insulin stimulates glucose 
transport via nitric oxide/cyclic GMP pathway in human vascular 
smooth muscle cells. Arterioscler Thromb Vasc Biol 23:2215–
2221. https ://doi.org/10.1161/01.ATV.00001 07028 .20478 .8e
Björne M, Herulf HM et al (2001) Nitrite-derived nitric oxide: a pos-
sible mediator of “acidic-metabolic” vasodilation. Acta Physiol 
Scand 171:9–16. https ://doi.org/10.1046/j.1365-201X.2001.17100 
1009.x
Brondum-Jacobsen P, Nordestgaard BG, Nielsen SF et al (2013) Skin 
cancer as a marker of sun exposure associates with myocardial 
infarction, hip fracture and death from any cause. Int J Epidemiol 
42:1486–1496
Carr G, Ferguson S (1990) Nitric oxide formed by nitrite reduc-
tase of Paracoccus denitrificans is sufficiently stable to inhibit 
cytochrome oxidase activity and is reduced by its reductase under 
aerobic conditions. Biochim Biophys Acta Bioenerg 1017:57–62. 
https ://doi.org/10.1016/0005-2728(90)90178 -7
Castello PR, David PS, McClure T et  al (2006) Mitochondrial 
cytochrome oxidase produces nitric oxide under hypoxic con-
ditions: implications for oxygen sensing and hypoxic signaling 
in eukaryotes. Cell Metab 3:277–287. https ://doi.org/10.1016/j.
cmet.2006.02.011
Dejam A, Kleinbongard P, Rassaf T et al (2003) Thiols enhance NO 
formation from nitrate photolysis. Free Radic Biol Med 35:1551–
1559. https ://doi.org/10.1016/j.freer adbio med.2003.09.009
Diffey BL (2002) Sources and measurement of ultraviolet radiation. 
Methods 28:4–13. https ://doi.org/10.1016/S1046 -2023(02)00204 
-9
Duncan C, Dougall H, Johnston P et al (1995) Chemical generation 
of nitric oxide in the mouth from the enterosalivary circulation 
of dietary nitrate. Nat Med 1:546–551. https ://doi.org/10.1038/
nm069 5-546
Fitzpatrick TB (1988) The validity and practicality of sun reactive skin 
types from I through to VI. Arch Dermatol 124:869–871
Fleury N, Geldenhuys S, Gorman S (2016) Sun exposure and its effects 
on human health: Mechanisms through which sun exposure could 
reduce the risk of developing obesity and cardiometabolic dys-
function. Int J Environ Res Public Health 13:1–18. https ://doi.
org/10.3390/ijerp h1310 0999
Geldenhuys S, Hart PH, Endersby R et al (2014) Ultraviolet radia-
tion suppresses obesity and symptoms of metabolic syndrome 
independently of vitamin d in mice fed a high-fat diet. Diabetes 
63:3759–3769. https ://doi.org/10.2337/db13-1675
Gemignani T, Matos-Souza JR, Coelho OR et  al (2008) Postural 
changes may influence popliteal atherosclerosis by modifying 
local circumferential wall tension. Hypertens Res 31:2059–2064. 
https ://doi.org/10.1291/hypre s.31.2059
Gorman S, Lucas RM, Allen-Hall A et al (2017) Ultraviolet radiation, 
vitamin D and the development of obesity, metabolic syndrome 
and type-2 diabetes. Photochem Photobiol Sci 16:362–373. https 
://doi.org/10.1039/C6PP0 0274A 
Hill JO, Wyatt HR, Reed GW, Peters JC (2003) Obesity and the envi-
ronment: where do we go from here? Sci 299:853–855
Holliman G, Lowe D, Cohen H et al (2017) Ultraviolet radiation-
induced production of nitric oxide:a multi-cell and multi-donor 
analysis. Sci Rep 7:1–11. https ://doi.org/10.1038/s4159 8-017-
11567 -5
Kapil V, Milsom AB, Okorie M et al (2010) Inorganic nitrate sup-
plementation lowers sytemic blood pressure. J Am Heart Assoc 
56:274–281. https ://doi.org/10.1161/HYPER TENSI ONAHA 
.110.15353 6
Kenjale AA, Ham KL, Stabler T et al (2011) Dietary nitrate supple-
mentation enhances exercise performance in peripheral arterial 
disease. J Appl Physiol 110:1582–1591. https ://doi.org/10.1152/
jappl physi ol.00071 .2011
Kennedy C, Bajdik CD, Willemze R et al (2003) The influence of 
painful sunburns and lifetime sun exposure on the risk of actinic 
keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and 
skin cancer. J Invest Dermatol 120:1087–1093. https ://doi.org/10
.1046/j.1523-1747.2003.12246 .x
Kleinbongard P, Dejam A, Lauer T et al (2006) Plasma nitrite concen-
trations reflect the degree of endothelial dysfunction in humans. 
Free Radic Biol Med 40:295–302. https ://doi.org/10.1016/j.freer 
adbio med.2005.08.025
Larsen FJ, Ekblom B, Sahlin K, Lundberg JO, Weitzberg E (2006) 
Effects of dietary nitrate on blood pressure in healthy vol-
unteers. N Engl J Med 355(26):2792–2793. https ://doi.
org/10.1056/NEJMc 06280 0
Larsen FJ, Schiffer TA, Borniquel S et al (2011) Dietary inorganic 
nitrate improves mitochondrial efficiency in humans. Cell Metab 
13:149–159. https ://doi.org/10.1016/j.cmet.2011.01.004
Larsen FJ, Schiffer TA, Ekblom B et  al (2014) Dietary nitrate 
reduces resting metabolic rate: a randomized, crossover study 
in humans. Am J Clin Nutr 99:843–850. https ://doi.org/10.3945/
ajcn.113.07949 1
Lawes CMM, Bennett DA, Feigin VL, Rodgers A (2004) Blood 
pressure and stroke: an overview of published reviews. Stroke 
35:776–785. https ://doi.org/10.1161/01.STR.00001 16869 
.64771 .5A
Liddle L, Monaghan C, Burleigh MC et al (2018) Changes in body pos-
ture alter plasma nitrite but not nitrate concentration in humans. 
Nitric Oxide Biol Chem 72:59–65. https ://doi.org/10.1016/j.
niox.2017.11.008
Liu D, Fernandez BO, Hamilton A et al (2014) UVA irradiation of 
human skin vasodilates arterial vasculature and lowers blood pres-
sure independently of nitric oxide synthase. J Invest Dermatol 
134:1839–1846. https ://doi.org/10.1038/jid.2014.27
Lundberg JO, Gladwin MT, Ahluwalia A et al (2009) Nitrate and nitrite 
in biology, nutrition and therapeutics. Nat Chem Biol 5:865–869. 
https ://doi.org/10.1038/nchem bio.260
Lundberg JO, Gladwin MT, Weitzberg E (2015) Strategies to increase 
nitric oxide signalling in cardiovascular disease. Nat Rev Drug 
Discov. https ://doi.org/10.1038/nrd46 23
Lusk G (1923) The elements of the science of nutrition, 18–25, 3rd edn. 
Saunders, Philadelphia, pp 468–472
Ma SX, Lee PC, Jiang I et al (2015) Influence of age, gender, and race 
on nitric oxide release over acupuncture points-meridians. Sci Rep 
5(1). https ://doi.org/10.1038/srep1 7547
Marionnet C, Tricaud C, Bernerd F (2015) Exposure to non-extreme 
solar UV daylight: spectral characterization, effects on skin and 
photoprotection. Int J Mol Sci 16:68–90. https ://doi.org/10.3390/
ijms1 60100 68
MacMahon S, Peto R, Cutler J et al (1990) Blood pressure, stroke, 
and coronary heart disease. Part 1, prolonged differences in 
blood pressure: prospective observational studies corrected for 
the regression dilution bias. Lancet 335:765–774
McIlvenna LC, Monaghan C, Liddle L et al (2017) Beetroot juice 
versus chard gel: a pharmacokinetic and pharmacodynamic 
1052 European Journal of Applied Physiology (2018) 118:1043–1052
1 3
comparison of nitrate bioavailability. Nitric Oxide Biol Chem 
64:61–67. https ://doi.org/10.1016/j.niox.2016.12.006
Modin A, Bjorne H, Herulf M et al (2001) Nitrite-derived nitric oxide: 
a possible mediator of ‘acidic-metabolic’ vasodilation. Acta Phys-
iol Scand 171:9–16
Moncada S, Higgs EA (1991) Endogenous nitric oxide: physiology, 
pathology and clinical relevance. Eur J Clin Invest 21:361–374. 
https ://doi.org/10.1111/j.1365-2362.1991.tb013 83.x
Mowbray M, McLintock S, Weerakoon R et al (2009) Enzyme-inde-
pendent NO stores in human skin: quantification and influence 
of UV radiation. J Invest Dermatol 129:834–842. https ://doi.
org/10.1038/jid.2008.296
Muggeridge DJ, Howe CCF, Spendiff O et al (2014) A single dose of 
beetroot juice enhances cycling performance in simulated alti-
tude. Med Sci Sports Exerc 46:143–150. https ://doi.org/10.1249/
MSS.0b013 e3182 a1dc5 1
Muggeridge DJ, Sculthorpe N, Grace FM et al (2015) Acute whole 
body UVA irradiation combined with nitrate ingestion enhances 
time trial performance in trained cyclists. Nitric Oxide 48:3–9. 
https ://doi.org/10.1016/j.niox.2014.09.158
Oberg AL, Ferguson JA, McIntyre LM et al (2000) Incidence of stroke 
and season of the year: evidence of an association. Am J Epide-
miol 152:558–555
Opländer C, Volkmar CM, Paunel-Görgülü A et al (2009) Whole body 
UVA irradiation lowers systemic blood pressure by release of 
nitric oxide from intracutaneous photolabile nitric oxide deriva-
tives. J Am Heart Assoc 105:1031–1040. https ://doi.org/10.1161/
CIRCR ESAHA .109.20701 9
Paunel AN, Dejam A, Thelen S et al (2005) Enzyme-independent nitric 
oxide formation during UVA challenge of human skin: characteri-
zation, molecular sources, and mechanisms. Free Radic Biol Med 
38:606–615. https ://doi.org/10.1016/j.freer adbio med.2004.11.018
Pinder AG, Rogers SC, Khalatbari A et al (2008) The measurement of 
nitric oxide and its metabolites in biological samples by ozone-
based chemiluminescence. In: Hancock JT (ed) Methods in molec-
ular biology. Humana Press, Totowa, pp 11–28
Rigel DS (2008) Cutaneous ultraviolet exposure and its relationship to 
the development of skin cancer. J Am Acad Dermatol 58:129–132. 
https ://doi.org/10.1016/j.jaad.2007.04.034
Rosengren A, Stegmayr B, Johansson I et al (1999) Coronary risk 
factors, diet and vitamins as possible explanatory factors of the 
Swedish north–south gradient in coronary disease: a comparison 
between two MONICA centres. J Intern Med 246:577–586
Siervo M, Lara J, Ogbonmwan I, Mathers JC (2013) Inorganic 
nitrate and beetroot juice supplementation reduces blood pres-
sure in adults: a systematic review and meta-analysis 1–3. J Nutr 
143:818–826. https ://doi.org/10.3945/jn.112.17023 3
Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA (1994) Nitric 
oxide regulates basal systemic and pulmonary vascular resistance 
in healthy humans. Circulation 89:2035–2040
Suschek CV, Opländer C, Van Faassen EE (2010) Non-enzymatic 
NO production in human skin: effect of UVA on cutaneous 
NO stores. Nitric Oxide 22:120–135. https ://doi.org/10.1016/j.
niox.2009.10.006
Tiso M, Schechter AN (2015) Nitrate reduction to nitrite, nitric oxide 
and ammonia by gut bacteria under physiological conditions. 
PLoS One 10:1–18. https ://doi.org/10.1371/journ al.pone.01197 12
Vanhatalo A, Bailey SJ, Blackwell JR et al (2010) Acute and chronic 
effects of dietary nitrate supplementation on blood pressure and 
the physiological responses to moderate-intensity and incremental 
exercise. Am J Physiol Regul Integr Comp Physiol 299:R1121-31. 
https ://doi.org/10.1152/ajpre gu.00206 .2010
Webb AJ, Patel N, Loukogeorgakis S et al (2008) Acute blood pressure 
lowering, vasoprotective, and antiplatelet properties of dietary 
nitrate via bioconversion to nitrite. Hypertension 51:784–790. 
https ://doi.org/10.1161/HYPER TENSI ONAHA .107.10352 3
Whitfield J, Ludzki A, Heigenhauser GJF et al (2016) Beetroot juice 
supplementation reduces whole body oxygen consumption but 
does not improve indices of mitochondrial efficiency in human 
skeletal muscle. J Physiol 594:421–435. https ://doi.org/10.1113/
JP270 844
Wylie LJ, Kelly J, Bailey SJ et al (2013) Beetroot juice and exercise: 
pharmacodynamic and dose-response relationships. J Appl Phys-
iol. https ://doi.org/10.1152/jappl physi ol.00372 .2013
Yang L, Lof M, Veierod MB et al (2011) Ultraviolet exposure and 
mortality among women in Sweden. Cancer Epidemiol Biomark 
Prev 20:683–690
